Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis

HepatitisHepatology

Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hcv-related cirrhosis

J Viral Hepat.

Masetti C, Lionetti , Lupo M, Siciliano M, Giannelli V, Ponziani FR, Teti E, Dell'Unto C, Francioso S, Brega A, Montalbano M, Visco-Comandini U, Taibi C, Galati G, Vespasiani Gentilucci U, Picardi A, Andreoni M, Pompili M, Pellicelli AM, D'Offizi G, Gasbarrini A, De Santis A, Angelico M

doi: 10.1111/jvh.12982.

Gastrointestinal CancerHepatology

Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection

J Hepatol.

Marasco G, Colecchia A, Colli A, Ravaioli F, Casazza G, Reggiani MLB, Cucchetti A, Cescon M, Festi D

doi: 10.1016/j.jhep.2018.10.022.

Gastrointestinal Cancer

Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

J Hepatol.

Ricke J, Klumpen HJ, Amthauer H, Bargellini I, Bartenstein P, de Toni E, Gasbarrini A, Pech M, Peck-Radosavljevic M, Popovič P, Rosmorduc O, Schott E, Seidensticker M, Verslype C, Sangro B, Malfertheiner P

doi: 10.1016/j.jhep.2019.08.006.

Hepatology

Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status

J Hepatol.

Audureau E, Carrat F, Layese R, Cagnot C, Asselah T, Guyader D, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Chazouillères O, Mallat A, Grangé JD, Attali P, d'Alteroche L, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Pol S, Nahon P, Nahon P, Marcellin P, Guyader D, Pol S, Fontaine H, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Leroy V, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Dharancy S, Blanc JF, Abergel A, Chazouillères O, Mallat A, Grangé JD, Attali P, Louis d'Alteroche, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, ANRS CO12 CirVir group

doi: 10.1016/j.jhep.2020.05.052.

Gastrointestinal CancerHepatology

A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma

J Hepatol.

Serenari M, Han KH, Ravaioli F, Kim SU, Cucchetti A, Han DH, Odaldi F, Ravaioli M, Festi D, Pinna AD, Cescon M

doi: 10.1016/j.jhep.2020.04.032.

HepatitisHepatology

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B

J Hepatol.

Papatheodoridis GV, Sypsa V, Dalekos GN, Yurdaydin C, Van Boemmel F, Buti M, Calleja JL, Chi H, Goulis J, Manolakopoulos S, Loglio A, Voulgaris T, Gatselis N, Keskin O, Veelken R, Lopez-Gomez M, Hansen BE, Savvidou S, Kourikou A, Vlachogiannakos J, Galanis K, Idilman R, Esteban R, Janssen H, Berg T, Lampertico P

doi: 10.1016/j.jhep.2020.01.007.

HepatitisHepatology

Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Am J Gastroenterol.

Chan TT, Chan WK, Wong GL, Chan AW, Nik Mustapha NR, Chan SL, Chong CC, Mahadeva S, Shu SS, Lai PB, Chan HL, Wong VW

doi: 10.14309/ajg.0000000000000588.

Hepatology

Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis

J Hepatol.

Jepsen P, Kraglund F, West J, Villadsen GE, Sørensen HT, Vilstrup H

doi: 10.1016/j.jhep.2020.05.043.

Hepatitis

Development of Hepatocellular Carcinoma by Patients Aged 75-84 with Chronic Hepatitis C Treated with Direct-acting Antivirals

J Infect Dis.

Ogawa E, Nomura H, Nakamuta M, Furusyo N, Kajiwara E, Dohmen K, Kawano A, Ooho A, Azuma K, Takahashi K, Satoh T, Koyanagi T, Ichiki Y, Kuniyoshi M, Yanagita K, Amagase H, Morita C, Sugimoto R, Kato M, Shimoda S, Hayashi J, Kyushu University Liver Disease Study (KULDS) Group.

doi: 10.1093/infdis/jiaa359.

Related content

Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hcv-related cirrhosis

Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection

Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status

A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B

Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease

Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis

Development of Hepatocellular Carcinoma by Patients Aged 75-84 with Chronic Hepatitis C Treated with Direct-acting Antivirals